Atorvastatin Calcium
Product Images NDC 43353-321

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 43353-321). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Bottle Label 80mg (43353 321)

Bottle Label 80mg (43353 321)
ATROVASTATIN CALCIUM 80 mg 90 Tablets label by Aphena Pharma Solutions. It shows the product name and strength prominently with dosage form as tablets. The label mentions the manufacturer site in Toronto, Canada, and states the product is for prescription use. The NDC code 43353-321-80 is visible along with serialization barcodes.*
FDA Label Image

Aphena Pharma Solutions (TN)

Aphena Pharma Solutions (TN)
FDA Label Image

Figure-01 (Figure 01)

Figure-01 (Figure 01)
A cumulative incidence graph comparing Atorvastatin and placebo groups over 3.5 years. The solid line represents Atorvastatin, and the dashed line represents placebo, showing lower cumulative incidence for Atorvastatin. The x-axis shows years, and the y-axis shows cumulative incidence percentage.*
FDA Label Image

Figure-02 (Figure 02)

Figure-02 (Figure 02)
A line graph comparing cumulative hazard percentages over time between Atorvastatin and placebo groups. The x-axis represents time in years up to four years, and the y-axis shows cumulative hazard percentage. Atorvastatin shows a lower cumulative hazard compared to placebo throughout the follow-up period, with a hazard ratio of 0.63 and p-value of 0.001 indicated on the graph.*
FDA Label Image

Figure-03 (Figure 03)

Figure-03 (Figure 03)
A line graph depicting the percentage of subjects experiencing a cardiovascular event over a five-year period. Two dosage groups of atorvastatin, 10 mg (dashed line) and 80 mg (solid line), are compared by time to first major cardiovascular endpoint, with hazard ratio and p-value indicated on the graph.*
FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)
Chemical structure of atorvastatin calcium showing its molecular composition with calcium ion complexation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.